Cannabidiol Market Size

  • Report ID: 6084
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Cannabidiol Market Size

Cannabidiol (CBD) Market size was valued at USD 7.64 billion in 2023 and is set to reach USD 50.87 billion by the end of 2036, registering around 15.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of CBD is assessed at USD 8.6 billion.

The growth of the market can be attributed to the medicinal properties of CBD oil, backed by the tremendous ongoing research on benefits of cannabis sativa. CBD oil has various medical uses in curing depression and anxiety, inflammation, and relieving symptoms of cancer. According to a report by the World Health Organization, CBD is proven as an effective treatment for epilepsy, in several clinical trials. Owing to increasing adoption of cannabinoids, especially CBD, in therapeutic and medical science, the market is estimated to grow substantially over the forecast period. Moreover, CBD lacks any kind of psychoactive effects, something very common in other cannabis products, which is estimated to boost the market growth despite the stringent regulations on consumption of cannabis sativa in any other form. Additionally, Increasing R&D activities regarding the advantages and side effects of cannabis, is projected to boost the market growth. 


Cannabidiol Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6084
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of cannabidiol was over USD 7 billion.

The market size for cannabidiol is projected to cross USD 41 billion by the end of 2036 expanding at a CAGR of 16% during the forecast period i.e., between 2024-2036.

The major players in the market are Medical Marijuana Inc., Cannoid, LLC, Isodiol International Inc., ENDOCA, Folium Biosciences, Aurora Cannabis Inc., Elixinol Global, CV Sciences, Medterra CBD, PharmaHemp, and others.

The hemp segment is anticipated to garner a share of 57% during 2024-2036.

The North America cannabidiol sector is poised to hold 35% share by the end of 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample